Skip to content

Control of hormone concentrations produced by the stomach and intestine by the use of a supplement containing yerba mate, guarana and damiana in women with overweight

Modulation of gastrointestinal hormones by supplementation herbal extract containing yerba mate, guaraná and damiana in overweight women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-99395b
Enrollment
Unknown
Registered
2015-07-30
Start date
2014-03-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity

Interventions

Experimental group: 20 subjects supplemented with herbal extract containing Yerba Mate (112mg), Guarana (95mg), Damiana (36mg)before breakfast and lunch. Placebo group: 20 subjects supplemented with c
Dietary supplement
SP6.051.227

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Universidade São Francisco
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: BMI 25 and 39,9 kg/m²;20 Sedentary women and healthy;Aged 20 to 50 years

Exclusion criteria

Exclusion criteria: Unavailability of one day/ week for the study day;participants with autoimmune liver kidney or hypothyroidism diseases; gastrointestinal symptoms requiring treatment; bariatric surgery;participants of a food restriction program or that practiced diet in the last 12 months to lose or control weight;without use current adherence to a specific food avoidance diet;taking medication or nutritional supplements known to affect appetite or weight;taking medication immunosuppressive or insulin; being pregnant or planning to become pregnant or breastfeeding; menopause;chronic alcoholics;history of anaphylaxis to food; food allergies, including caffeine or other compound present in the supplement and any of the study foods;intolerance or allergy to lactose

Design outcomes

Primary

MeasureTime frame
Reduction in energy intake at breakfast and lunch assessed by weighing the food leftover, from the finding of a difference of at least 5% between groups. Reduction in the area under the curve for the ghrelin concentrations after breakfast and lunch assessed by biochemical analysis (multiplex system), based on the statement of a difference of at least 20% in both groups. Significant reduction in the area under the curve for acylated ghrelin concentration, based on the statement of the difference between groups of 177.41% only after lunch.;Increasing the area under the curve for concentrations of GLP-1 after breakfast and lunch evaluated by biochemical analysis (multiplex system), from finding a difference of at least 20% between groups. Significant increase in the area under the curve for GLP-1 concentration, based on the statement of the difference between groups of 625% only after breakfast.;Significant increase in the area under the curve for GLP-1 concentration, based on the statement of the difference between groups of 625% only after breakfast.

Secondary

MeasureTime frame
Reduction in glucose concentrations after breakfast and lunch evaluated through digital glucometer from the observation that a difference of at least 5% between groups. Significant reductions in glucose concentrations between 90 and 210 minutes after breakfast, based on the statement of the 5% difference between the groups. Reducing the feeling of hunger after breakfast and lunch assessed by visual analog scale, based on the statement of difference of at least 10% between groups.

Countries

Brazil

Contacts

Public ContactMarina Celestino

Universidade Federal de Goiás

marinamonteiroc@hotmail.com+556281767888

Outcome results

None listed

Source: REBEC (via WHO ICTRP)